Poland – Pharmaceutical products – Supply of medicines and infusion fluids

Opportunity description

1. The subject matter of the contract is the successive supply, upon the Contracting Authority’s orders, of medicines and infusion fluids, divided into 9 lots. 2. A detailed description of the subject matter of the contract, including the assortment, doses, forms and quantities, is specified in Annex No. 2 to the SWZ – Assortment and Price Form. 3. The assortment constituting the subject matter of the contract must be authorized for marketing and use in the territory of the Republic of Poland in accordance with the Act of 6 September 2001 – Pharmaceutical Law (consolidated text: Journal of Laws 2026, item 612). The Contractor is required to possess all documents required by law authorizing the offered medicinal products for marketing and to present them at the Contracting Authority’s request (excluding medicinal products imported under the named-patient import procedure). 4. The submitted tenders must state the trade name of the preparation, package size, manufacturer’s name, GTIN/EAN code, marketing authorization number and detailed product information. If the offered medicine package contains a different number of units (e.g. tablets, ampoules), the Contractor is required to recalculate the number of packages accordingly. If the resulting number of packages is not a whole number, the quantity must be rounded up to a full package. The EAN (GTIN) code indicated in the Assortment and Price Form is for information purposes and serves to identify the offered product as at the tender submission date. A change to the EAN (GTIN) code during the term of the contract resulting from a change in packaging, distributor or trade designation, while retaining the same active substance, dose, pharmaceutical form and marketing authorization number, does not constitute a change to the content of the tender or an amendment to the contract. 5. The Contracting Authority permits tablets to be substituted with capsules (and vice versa) and ampoules to be substituted with vials (and vice versa), provided that the same form of the medicine is retained. However, it does not permit prolonged-release and modified-release medicines to be substituted with a medicine in the conventional form of a tablet, coated tablet or capsule. 6. To maintain the safety of pharmacotherapy, the Contracting Authority requires that different doses of the same medicinal product included in one Task come from a single manufacturer – this applies to the same form of the medicine. Narcotic drugs and psychotropic medicines 1 Narcotic drugs and psychotropic medicines 2 Antibiotics 1 Antibiotics 2 Antibiotics 3 Antibiotics 4 Antibiotics 5 Miscellaneous medicines 23 Infusion fluids 2 Procedure: open. Review the original TED notice for the complete requirement, lots, amendments and attachments.